Vimarsana
Biggest News Aggregation in the World

Dna Methylation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dna Methylation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dna Methylation Today - Breaking & Trending Today

How Old Are You Really? New 'Aging' Clock Provides Clues - Vimarsana News

How Old Are You Really? New 'Aging' Clock Provides Clues

We age along two clocks: a chronological clock and a biological clock. The two don’t always align: some people may be biologically "younger" than their chronological age would suggest, and others, older.

Source: forbes.com
Advancements in Multi-Biomarker Cancer Testing - Vimarsana News

Advancements in Multi-Biomarker Cancer Testing

Key opinion leaders review the rationale behind multi-biomarker approaches and how they're shaping the future of cancer detection and research.

Addressing Healthcare Inequity With Accessible Multicancer Early Detection - Vimarsana News

Addressing Healthcare Inequity With Accessible Multicancer Early Detection

The potential of MCED testing to reduce health inequities and an examination of accessibility, including FDA approval, physician education, patient awareness, affordability, and logistical support.

Genomics Project Improves Global Diversity in Population Health Insight - Vimarsana News

Genomics Project Improves Global Diversity in Population Health Insight

Researchers emphasized the need for diverse genetic databases to comprehend factors affecting gene regulation and disease risk more effectively.

Biomarker brainteaser: Aging? Or just changing? - Vimarsana News

Biomarker brainteaser: Aging? Or just changing?

“Change is the only constant” is an ageless truth. In the search for age-related biomarkers, it is also a prosaic confounding factor. Age-related biomarkers will be critical for the development of antiaging therapeutics. “Nobody is planning to do a life span study in humans,” Eric Verdin told the audience at the 10th Conference on Aging Research and Drug Development in Copenhagen on Monday. “Hence the need for … surrogate markers.” And “we are not there … we are actually quite far from there.”